Recombinant Xenopus tropicalis Cytosolic phospholipase A2 (pla2g4a), partial

Shipped with Ice Packs
In Stock

Description

Molecular Characterization

PLA2G4A encodes a calcium-dependent cytosolic phospholipase A2 (cPLA2) critical for lipid remodeling and inflammatory signaling. The recombinant partial protein retains functional domains necessary for substrate binding and catalysis.

PropertyDetails
SpeciesXenopus tropicalis
Gene IDHomolog of human PLA2G4A (NCBI Gene: 5321)
Protein DomainsPartial sequence includes catalytic α/β hydrolase domain and calcium-dependent C2 domain .
Expression SystemTypically produced in baculovirus or mammalian systems for post-translational modifications .
Key MotifsCatalytic triad (Ser-Asp-His) and conserved GxSxG lipase motif .

3.1. Inflammatory Pathways

  • PLA2G4A-derived arachidonic acid fuels prostaglandin and leukotriene synthesis, linking it to inflammation and immune responses .

  • Inhibitors like AACOCF3 and ASB 14780 target its catalytic site, reducing pro-inflammatory lipid mediators .

3.2. Viral Pathogenesis

  • PLA2G4A activity is essential for producing infectious hepatitis C virus (HCV) and Dengue virus particles, likely by shaping lipid membranes for virion assembly .

  • Pharmacological inhibition reduces viral infectivity by >100-fold, highlighting its therapeutic potential .

3.3. Neurological Injury

  • In spinal cord injury models, PLA2G4A inhibition mitigates secondary tissue damage and improves motor recovery, suggesting neuroprotective applications .

Comparative Analysis with Human PLA2G4A

FeatureXenopus tropicalis PLA2G4AHuman PLA2G4A
GenomeDiploid, aiding genetic studiesAllotetraploid (post-tetraploid)
Catalytic EfficiencyConserved Ser-Asp-His triad Similar triad (Ser-228, Asp-549)
Functional StudiesLimited direct data; inferred from human homologsWell-characterized in inflammation, cancer, and infection

Production and Purification

  • Expression: Recombinant partial PLA2G4A is often expressed in insect cells (e.g., baculovirus) to ensure proper folding and phosphorylation at regulatory sites (e.g., Ser-505) .

  • Purity: ≥87% purity achieved via affinity chromatography, validated by SDS-PAGE and functional assays .

  • Storage: Stable at -80°C in lyophilized form, avoiding freeze-thaw cycles .

Key Research Findings

  1. Lipid Mediator Biosynthesis:

    • PLA2G4A knockout in mice disrupts embryo implantation due to deficient prostaglandin synthesis .

    • In Xenopus, conserved catalytic mechanisms suggest analogous roles in development .

  2. Therapeutic Targeting:

    • Pyropheophorbide-a (Py-2), a cPLA2 inhibitor, blocks HCV particle infectivity by altering lipid composition .

    • Genetic deletion of PLA2G4A in mice reduces spinal cord injury severity by 50% .

Future Directions

  • Structural Biology: Cryo-EM studies of Xenopus PLA2G4A could elucidate evolutionary divergence from mammalian isoforms.

  • Genetic Models: Leverage Xenopus tropicalis for CRISPR-based mutagenesis to study PLA2G4A roles in development and disease .

Product Specs

Form
Lyophilized powder. Note: We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time may vary based on purchasing method and location. Please consult your local distributors for specific delivery times. Note: All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional fees apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag, please inform us, and we will prioritize developing it.
Synonyms
pla2g4a; cpla2; pla2g4; Cytosolic phospholipase A2; cPLA2; Phospholipase A2 group IVA) [Includes: Phospholipase A2; EC 3.1.1.4; Phosphatidylcholine 2-acylhydrolase); Lysophospholipase; EC 3.1.1.5)]
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)
Target Names
Uniprot No.

Target Background

Function
Selectively hydrolyzes arachidonyl phospholipids at the sn-2 position, releasing arachidonic acid. Along with its lysophospholipid activity, it plays a role in initiating the inflammatory response.
Database Links
Subcellular Location
Cytoplasm. Cytoplasmic vesicle.

Q&A

What is the functional role of PLA2G4A in Xenopus tropicalis?

In Xenopus tropicalis, as in other vertebrates, cytosolic phospholipase A2 (PLA2G4A) plays critical roles in membrane lipid remodeling and biosynthesis of lipid mediators involved in inflammatory responses. The enzyme selectively hydrolyzes arachidonyl phospholipids in the sn-2 position, releasing arachidonic acid, which serves as a precursor for eicosanoid biosynthesis via the cyclooxygenase pathway . This hydrolysis reaction simultaneously produces lysophospholipids that can be converted into platelet-activating factor.

In developmental contexts, PLA2G4A is particularly important for processes requiring lipid signaling cascades. The protein demonstrates calcium-dependent phospholipase and lysophospholipase activities, with activation occurring through increased intracellular Ca²⁺ levels and phosphorylation events that trigger its translocation from cytosolic and nuclear compartments to perinuclear membrane vesicles .

How does Xenopus tropicalis PLA2G4A compare structurally and functionally to mammalian orthologs?

While the search results don't provide specific comparative data between Xenopus tropicalis PLA2G4A and mammalian orthologs, general molecular principles suggest conservation of key functional domains. The protein belongs to the cytosolic phospholipase A2 group IV family and contains calcium-binding domains that regulate its activity .

Similar to human PLA2G4A, the Xenopus variant likely demonstrates:

  • Calcium-dependent activation mechanisms

  • Selectivity for arachidonoyl phospholipids at the sn-2 position

  • Translocation properties following activation

  • Roles in inflammatory response and lipid signaling pathways

The partial recombinant form may contain the catalytic domain responsible for phospholipase activity but might lack some regulatory domains present in the full-length protein.

What are the characteristics of recombinant partial PLA2G4A from Xenopus tropicalis?

Recombinant partial PLA2G4A from Xenopus tropicalis typically consists of selected functional domains of the native protein expressed in heterologous systems. While specific details about the Xenopus tropicalis variant are not provided in the search results, the partial recombinant form would likely retain the catalytic domain necessary for phospholipase A2 activity .

Production systems for recombinant proteins generally include bacterial (E. coli), yeast, baculovirus-infected insect cells, or mammalian expression systems. Each system offers distinct advantages:

Expression SystemAdvantagesLimitations
E. coliHigh yield, cost-effective, rapidMay lack post-translational modifications, potential inclusion bodies
YeastPost-translational processing, higher yield than mammalianMay have different glycosylation patterns
BaculovirusHigher eukaryotic post-translational modificationsMore complex, moderate yield
Mammalian cellsNative-like post-translational modificationsLower yield, higher cost, longer production time

The partial nature of the recombinant protein may be intentional to improve solubility, enhance expression levels, or isolate specific functional domains for research applications .

What are the optimal conditions for assaying recombinant Xenopus PLA2G4A activity in vitro?

Assaying recombinant Xenopus PLA2G4A activity requires careful consideration of several conditions that mimic its physiological activation state. The enzyme is calcium-dependent and requires specific pH and temperature conditions that approximate the Xenopus physiological environment .

A typical assay protocol would include:

  • Buffer composition: pH 7.4-8.0 phosphate or Tris buffer with 1-5 mM CaCl₂

  • Temperature: 25-30°C (appropriate for a poikilothermic organism like Xenopus)

  • Substrate preparation: Phospholipid substrates containing arachidonoyl groups at the sn-2 position

  • Activation: Addition of Ca²⁺ to final concentration of 1-5 mM

  • Activity measurement: Quantification of released arachidonic acid or lysophospholipids using chromatographic methods or coupled enzymatic assays

Researchers should note that PLA2G4A requires activation via calcium and often benefits from phosphorylation. Pre-incubation with protein kinases and ATP can enhance activity, mimicking the physiological activation cascades .

How can I establish an expression system for producing recombinant Xenopus tropicalis PLA2G4A?

Establishing an expression system for recombinant Xenopus tropicalis PLA2G4A requires several key steps:

  • Gene synthesis or cloning: Obtain the coding sequence for Xenopus tropicalis PLA2G4A. For partial protein expression, identify the functional domains of interest.

  • Expression vector selection: Choose an appropriate expression vector containing:

    • Strong promoter suitable for your expression system

    • Affinity tag sequence (His6, GST, etc.) for purification

    • Appropriate selection marker

  • Expression system selection: Based on Table 1, select an expression system that balances yield requirements with protein functionality needs .

  • Optimization of expression conditions:

    • For E. coli: Test various strains (BL21(DE3), Rosetta), induction temperatures (16-37°C), and IPTG concentrations

    • For eukaryotic systems: Optimize transfection/infection parameters, culture medium, and harvest timing

  • Purification strategy:

    • Immobilized metal affinity chromatography for His-tagged proteins

    • Glutathione affinity for GST-tagged proteins

    • Ion exchange or size exclusion chromatography for further purification

For challenging proteins, consider adding solubility enhancers (SUMO tag) or using specialized expression strains designed for membrane-associated proteins .

What antibodies and detection methods are available for studying Xenopus tropicalis PLA2G4A?

While the search results don't provide specific antibodies for Xenopus tropicalis PLA2G4A, there are several approaches for detecting and studying this protein:

  • Cross-reactive antibodies: Human, mouse, and rat PLA2G4A antibodies may cross-react with the Xenopus ortholog due to evolutionary conservation. Available antibodies include :

    • Conventional unmodified antibodies for techniques like Western blotting, ELISA, and immunohistochemistry

    • Conjugated antibodies (HRP, FITC, or biotin) for specialized applications

  • Custom antibody development: Using recombinant Xenopus tropicalis PLA2G4A as an immunogen to generate specific antibodies.

  • Detection methods:

    • Western blotting for protein expression levels and post-translational modifications

    • Immunohistochemistry for tissue localization

    • Immunofluorescence for subcellular localization

    • ELISA for quantitative detection

    • Chromatin immunoprecipitation for DNA-protein interaction studies, as demonstrated in Xenopus tissues

When using antibodies, validation is essential through techniques such as knockout controls, peptide competition assays, or detection of recombinant protein standards .

How does PLA2G4A expression change during Xenopus development and metamorphosis?

The expression patterns of PLA2G4A during Xenopus development and metamorphosis likely correlate with stages requiring active lipid signaling and inflammatory responses. While the search results don't provide specific data for PLA2G4A expression in Xenopus tropicalis, metamorphosis studies in this species offer insights into gene regulation mechanisms that would apply to PLA2G4A .

Xenopus metamorphosis involves comprehensive remodeling of tissues under thyroid hormone (TH) control. Based on studies of metamorphic gene regulation:

  • Gene expression changes dramatically during metamorphosis, with peak regulation at Nieuwkoop-Faber stage 62 (NF62), when liganded thyroid hormone receptors (TRs) actively regulate transcription .

  • PLA2G4A expression likely follows tissue-specific patterns correlated with:

    • Inflammatory processes during tissue remodeling

    • Lipid signaling changes as tissues transform from larval to adult forms

    • Calcium signaling pathways activated during development

  • Techniques for studying PLA2G4A expression during development include:

    • Stage-specific RNA-seq to track transcript levels

    • Chromatin immunoprecipitation (ChIP) to identify potential thyroid hormone response elements in the PLA2G4A promoter

    • Whole-mount in situ hybridization to visualize tissue-specific expression patterns

Understanding these expression patterns could reveal new roles for PLA2G4A in amphibian development and tissue remodeling, particularly in relation to inflammatory signaling during metamorphosis .

What are the challenges in analyzing PLA2G4A transcriptional and post-transcriptional regulation?

Analyzing PLA2G4A regulation at transcriptional and post-transcriptional levels presents several technical and biological challenges:

  • Transcriptional regulation complexities:

    • Identifying tissue-specific promoters and enhancers that regulate PLA2G4A expression

    • Characterizing transcription factor binding sites using techniques like ChIP-seq

    • Understanding three-dimensional chromatin organization, including topologically associating domains (TADs) that may influence PLA2G4A expression

  • Post-transcriptional regulation challenges:

    • Alternative splicing events may generate multiple PLA2G4A transcript variants with distinct functions

    • Differential exon usage (DEU) analysis requires sophisticated RNA-seq and computational approaches

    • Transcript biotype analysis to distinguish between protein-coding variants and regulatory RNAs

  • Methodological considerations:

    • RNA extraction and quality control from different Xenopus tissues

    • Poly(A) mRNA enrichment before library preparation

    • Advanced computational analysis pipelines for detecting subtle regulation events

The analysis becomes particularly challenging when studying rapid adaptive responses, where post-transcriptional dynamics may change quickly and experimental conditions must be precisely controlled .

How can I use CRISPR/Cas9 to study PLA2G4A function in Xenopus tropicalis?

CRISPR/Cas9 genome editing offers powerful approaches to study PLA2G4A function in Xenopus tropicalis:

  • Knockout strategy:

    • Design sgRNAs targeting early exons of PLA2G4A

    • Inject Cas9 protein and sgRNAs into fertilized Xenopus tropicalis eggs

    • Screen F0 embryos for mosaic mutations and raise to adulthood

    • Breed F0 founders to generate F1 heterozygotes with germline mutations

    • Establish homozygous knockout lines through F1 crosses

  • Domain-specific editing:

    • Target specific functional domains (catalytic site, calcium-binding domain)

    • Design repair templates for homology-directed repair to introduce precise mutations

    • Analyze the effects on protein function and cellular phenotypes

  • Phenotypic analysis of PLA2G4A mutants:

    • Assess development progression and metamorphosis timing

    • Evaluate inflammatory responses in different tissues

    • Measure arachidonic acid release and eicosanoid production

    • Analyze calcium-dependent signaling pathways

  • Complementation studies:

    • Rescue knockout phenotypes with wildtype or mutant mRNA injections

    • Express tagged versions for localization studies

    • Introduce orthologous genes to assess functional conservation

This approach allows precise dissection of PLA2G4A function in developmental contexts, inflammatory responses, and tissue remodeling during metamorphosis.

How has PLA2G4A evolved across vertebrate lineages, and what insights does the Xenopus ortholog provide?

PLA2G4A has evolved to maintain its critical function in lipid signaling across vertebrate lineages while adapting to species-specific physiological requirements. The Xenopus tropicalis ortholog provides unique evolutionary insights:

  • Functional conservation:

    • Core enzymatic functions (hydrolysis of sn-2 arachidonoyl phospholipids) are likely conserved across vertebrates

    • Calcium-dependent activation mechanisms represent an ancient regulatory mechanism

    • Involvement in inflammatory response pathways reflects fundamental vertebrate physiology

  • Adaptive specializations:

    • Temperature sensitivity adaptations in poikilothermic animals like Xenopus compared to mammals

    • Potential differences in regulatory domains reflecting distinct signaling contexts

    • Specialized roles during metamorphosis, a process absent in mammals

  • Comparative analysis approaches:

    • Sequence alignment of catalytic and regulatory domains across species

    • Structural modeling to identify species-specific features

    • Functional assays comparing enzymatic properties under different conditions

The amphibian PLA2G4A represents an important evolutionary intermediate between fish and mammals, potentially revealing mechanisms of adaptation during vertebrate terrestrialization.

What techniques are available for comparative functional studies of PLA2G4A across species?

Comparative functional studies of PLA2G4A across species require integrated approaches:

  • Biochemical characterization:

    • Side-by-side enzymatic assays of recombinant PLA2G4A from different species

    • Determination of kinetic parameters (Km, Vmax) under standardized conditions

    • Substrate preference analysis using diverse phospholipid substrates

    • Calcium sensitivity and activation thresholds comparison

  • Cell-based functional assays:

    • Heterologous expression in conserved cell backgrounds

    • Complementation studies in knockout cell lines

    • Subcellular localization comparison using fluorescent protein fusions

    • Response to stimuli that activate phospholipase pathways

  • Structural biology approaches:

    • X-ray crystallography or cryo-EM of recombinant proteins

    • Molecular dynamics simulations to assess conformational differences

    • Hydrogen-deuterium exchange mass spectrometry for dynamics comparison

  • In vivo cross-species approaches:

    • Rescue experiments using orthologous genes in knockout models

    • Humanized animal models expressing mammalian PLA2G4A in Xenopus

    • Chimeric proteins to identify species-specific functional domains

These comparative approaches can reveal both conserved mechanisms and species-specific adaptations in PLA2G4A function across evolutionary time.

How can I optimize protein yield and activity when expressing recombinant Xenopus tropicalis PLA2G4A?

Optimizing recombinant Xenopus tropicalis PLA2G4A expression requires addressing several key challenges:

  • Expression system selection:

    • For full-length PLA2G4A: Eukaryotic systems (baculovirus or mammalian) preserve post-translational modifications and proper folding

    • For partial PLA2G4A: E. coli or yeast systems may provide sufficient yield with simpler protocols

  • Expression optimization strategies:

    • Temperature: Lower temperatures (16-25°C) often improve folding for complex proteins

    • Induction conditions: Reduced inducer concentration with extended expression time

    • Media formulation: Enriched media with osmotic stabilizers for membrane-associated proteins

    • Codon optimization: Adjust codons for the expression host to improve translation efficiency

  • Solubility enhancement approaches:

    • Fusion partners: SUMO, MBP, or TRX tags to improve solubility

    • Solubilizing agents: Mild detergents for membrane-associated domains

    • Chaperone co-expression: GroEL/ES, DnaK/J/GrpE systems to assist folding

  • Activity preservation strategies:

    • Calcium supplementation during purification

    • Reducing agents to preserve cysteine residues

    • Lipid reconstitution for membrane-associated domains

    • Stabilizing excipients: Glycerol, specific phospholipids, osmolytes

Systematic optimization of these parameters through small-scale expression trials before scaling up can significantly improve both yield and activity .

What are the key considerations for designing knockout or knockdown experiments for PLA2G4A in Xenopus tropicalis?

Designing effective knockout or knockdown experiments for PLA2G4A in Xenopus tropicalis requires careful planning:

  • Target selection strategies:

    • For CRISPR/Cas9: Target early exons or critical functional domains

    • For morpholinos: Target translation start site or exon-intron junctions

    • For RNAi: Select unique sequences not present in paralogous genes

  • Control design considerations:

    • Off-target assessment tools for CRISPR guide RNAs

    • Mismatch controls for morpholinos

    • Scrambled sequence controls for RNAi

    • Rescue experiments with wild-type mRNA to confirm specificity

  • Delivery methods optimization:

    • Microinjection timing: One-cell stage for uniform distribution

    • Injection location: Animal pole for broad distribution, specific blastomeres for targeted knockdown

    • Electroporation parameters for tissue-specific delivery in later stages

  • Validation approaches:

    • Genomic PCR and sequencing for CRISPR edits

    • RT-PCR to confirm splicing alterations with morpholinos

    • Western blotting to verify protein reduction

    • Enzymatic activity assays to confirm functional knockdown

  • Phenotypic analysis planning:

    • Developmental staging to identify critical periods

    • Tissue-specific markers to assess localized effects

    • Lipid mediator profiling to confirm biochemical consequences

    • Inflammation models to test functional outcomes

Careful documentation of developmental timing, environmental conditions, and complete characterization of molecular alterations are essential for reproducible results .

How can chromatin immunoprecipitation (ChIP) protocols be adapted for studying transcriptional regulation of PLA2G4A in Xenopus tissues?

Adapting chromatin immunoprecipitation (ChIP) protocols for Xenopus tissues requires several modifications to standard protocols:

  • Sample preparation considerations:

    • Tissue-specific isolation: Brain, liver, or whole embryos at specific developmental stages

    • Pooling of samples: 5+ embryos/tissues per replicate for sufficient chromatin yield

    • Crosslinking optimization: 1% formaldehyde for 10-15 minutes at room temperature

  • Chromatin fragmentation strategies:

    • Sonication parameters: Lower power settings with increased cycle numbers

    • Fragment size target: 200-500 bp for standard ChIP, 100-300 bp for ChIP-seq

    • Quality control: Agarose gel verification of fragmentation efficiency

  • Immunoprecipitation optimization:

    • Antibody selection: Validated for Xenopus proteins or conserved epitopes

    • Pre-clearing: Extended incubation with protein A/G beads to reduce background

    • Controls: Input DNA, IgG control, and positive control regions (known targets)

  • Analysis approaches:

    • qPCR targets: Promoter regions, potential enhancers, and intronic regulatory elements

    • ChIP-seq library preparation: Specialized kits for limited material

    • Bioinformatic analysis: Xenopus tropicalis genome alignment and peak calling

A typical workflow based on successful Xenopus experiments includes:

  • Chromatin isolation from whole brain or specific tissues

  • Fragmentation via sonication

  • Immunoprecipitation using 5 μg chromatin per reaction

  • Analysis via qPCR or sequencing

This approach can identify transcription factor binding sites and histone modifications associated with PLA2G4A regulation during development and in response to physiological stimuli.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.